DAPAGLIFLOZIN+VILDAGLIPTIN
About
DAPAGLIFLOZIN+VILDAGLIPTIN is an antidiabetic medicine used to treat diabetes. It is used for the treatment of Type II Diabetes. Type II Diabetes Mellitus is a chronic condition that influences the body's metabolism of glucose or blood sugar. Insulin resistance or insufficient insulin production are the two main causes of type 2 diabetes.
DAPAGLIFLOZIN+VILDAGLIPTIN contains Dapagliflozin (sodium-glucose cotransporter-2 inhibitors) and Vildagliptin (dipeptidyl peptidase-4 inhibitor), which work by increasing the amounts of certain natural substances that lower blood sugar when it is high.
DAPAGLIFLOZIN+VILDAGLIPTIN may cause certain side effects, such as vomiting, nausea, dizziness, abdominal pain, headache, frequent urination, and allergic reactions. If these side effects persist or worsen, please consult your doctor. DAPAGLIFLOZIN+VILDAGLIPTIN should be taken as prescribed by your doctor.
DAPAGLIFLOZIN+VILDAGLIPTIN should be avoided if you are allergic to any of the medicines or their components. Inform your doctor about your medical history and the medicines you are taking, including herbs and supplements, before starting the treatment with DAPAGLIFLOZIN+VILDAGLIPTIN. This can help prevent unwanted effects. Let your doctor know if you are pregnant or breastfeeding before taking DAPAGLIFLOZIN+VILDAGLIPTIN. It is not recommended for use in children below 18 years of age.
Uses of DAPAGLIFLOZIN+VILDAGLIPTIN
Medicinal Benefits
DAPAGLIFLOZIN+VILDAGLIPTIN is a combination medicine containing Dapagliflozin and Vildagliptin. DAPAGLIFLOZIN+VILDAGLIPTIN belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus. Dapagliflozin helps remove excess sugar from the body via urine. Vildagliptin enhances glucose-mediated insulin secretion, thereby reducing fasting and post-prandial blood sugar concentrations.
Directions for Use
Storage
Side Effects of DAPAGLIFLOZIN+VILDAGLIPTIN
- Headache
- Nausea
- Stomach upset
- Vomiting
- Abdominal pain
- Allergic reactions
- Painful urination
- Hypoglycaemia (low blood sugar)
- Dizziness
- Frequent urination
In-Depth Precautions and Warning
Drug Warnings
Do not take DAPAGLIFLOZIN+VILDAGLIPTIN if you are allergic to any of its components. Before starting the treatment, inform your doctor about your medical history and the medications you take, including herbs and supplements, to rule out any side effects. Inform your doctor if you have any liver/kidney disease, heart problems, and hypertension before taking DAPAGLIFLOZIN+VILDAGLIPTIN. This medicine is not recommended for children as safety and effectiveness have not been established. Avoid drinking alcohol while on DAPAGLIFLOZIN+VILDAGLIPTIN as it increases the risk of hypoglycemia and lactic acidosis (when the lactic acid increases in the body, which impacts the functioning of various organs in the body). It is unknown whether DAPAGLIFLOZIN+VILDAGLIPTIN can be given to pregnant women or breastfeeding mothers. Hence, inform your doctor if you are pregnant or breastfeeding. It is not recommended for use in children below 18 years of age. DAPAGLIFLOZIN+VILDAGLIPTIN may cause dizziness; hence, drive or operate machines only if you are alert.
Drug Interactions
Drug-Drug Interactions: DAPAGLIFLOZIN+VILDAGLIPTIN may interact with anti-diabetic (insulin glargine), diuretics (furosemide), hormone (levothyroxine) and corticosteroids.
Drug-Food Interactions: Avoid alcohol consumption.
Drug-Disease Interactions: Inform your doctor if you have hypoglycaemia (low blood sugar levels), heart problems and liver/kidney disease.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
unsafeAvoid consumption of alcohol during treatment with DAPAGLIFLOZIN+VILDAGLIPTIN as it may cause serious side effects.
Pregnancy
cautionIf you are pregnant or planning pregnancy, inform your doctor before starting treatment with DAPAGLIFLOZIN+VILDAGLIPTIN. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
unsafeDAPAGLIFLOZIN+VILDAGLIPTIN is generally not recommended in breastfeeding. Hence, if you are breastfeeding, inform your doctor before using DAPAGLIFLOZIN+VILDAGLIPTIN.
Driving
unsafeDAPAGLIFLOZIN+VILDAGLIPTIN may cause dizziness and make you drowsy. Hence, drive only if you are alert after taking this medicine.
Liver
cautionIf you have a pre-existing or a history of liver disease, inform your doctor before taking DAPAGLIFLOZIN+VILDAGLIPTIN. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Kidney
cautionIf you have a pre-existing or a history of kidney disease, inform your doctor before taking DAPAGLIFLOZIN+VILDAGLIPTIN. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
unsafeDAPAGLIFLOZIN+VILDAGLIPTIN is not recommended for use in children below 12 years of age as the safety and efficacy are not established.
Habit Forming
Diet & Lifestyle Advise
- Eat foods rich in healthy carbohydrates and fibre, fruits, whole grains, and vegetables.
- Try eating food at regular intervals. Do not skip meals. Also, try not to overeat.
- Follow a healthy diet and walk/exercise for at least 45 minutes.
- Maintain a healthy weight by exercising regularly.
- Avoid taking too much stress as it may elevate your blood sugar level. You can adopt stress management techniques like mindfulness to control stress-related blood sugar changes, meditation, or yoga.
- Keep your blood pressure as normal (140/90) as possible, as it reduces the risk of cardiovascular diseases in diabetes patients.
- Avoid smoking and alcohol consumption while on treatment with DAPAGLIFLOZIN+VILDAGLIPTIN.
Special Advise
- Regularly monitor blood glucose levels while taking DAPAGLIFLOZIN+VILDAGLIPTIN.
- Try not to skip any doses and take DAPAGLIFLOZIN+VILDAGLIPTIN for as long as your doctor has prescribed it for you.
- Always carry a sugary food such as candy or fruit juice and consume them if you experience hypoglycaemia.
- Lifestyle modifications are the most important step in controlling blood sugar levels.
Patients Concern
Disease/Condition Glossary
Type II Diabetes Mellitus: It is a chronic and lifelong condition wherein the body doesn’t use insulin effectively, which causes unusual blood glucose levels. Therefore, people affected with type 2 diabetes either do not produce enough insulin or there is resistance to the action of insulin. Individuals middle-aged or older are most likely to suffer from type 2 diabetes, which is also known as adult-onset diabetes. Symptoms of type 2 diabetes include increased thirst, frequent urination at night, slow wound healing, increased hunger, fatigue, weight gain, and blurred vision.
FAQs
DAPAGLIFLOZIN+VILDAGLIPTIN is an antidiabetic medicine used to treat Type II Diabetes. Dapagliflozin helps remove excess sugar from the body via urine. Vildagliptin enhances glucose-mediated insulin secretion, thereby reducing fasting and post-prandial blood sugar concentrations.
If you forget to take DAPAGLIFLOZIN+VILDAGLIPTIN, take it as soon as you remember. However, if it's time for the next dose, avoid taking it and do not double dose to make up for the missed dose. Taking an overdose might cause your sugar level to fall down rapidly.
In DAPAGLIFLOZIN+VILDAGLIPTIN, Dapagliflozin helps remove excess sugar from the body via urine. Vildagliptin enhances glucose-mediated insulin secretion, thereby reducing fasting and post-prandial blood sugar concentrations.
DAPAGLIFLOZIN+VILDAGLIPTIN may cause headache, nausea, stomach upset, vomiting, abdominal pain, allergic reactions, painful urination, hypoglycaemia (low blood sugar), dizziness and frequent urination.
